Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2009

01-09-2009 | Brief Report

Lobular involution: localized phenomenon or field effect?

Authors: Robert A. Vierkant, Lynn C. Hartmann, V. Shane Pankratz, Stephanie S. Anderson, Derek Radisky, Marlene H. Frost, Celine M. Vachon, Karthik Ghosh, Tammy J. Distad, Amy C. Degnim, Carol A. Reynolds

Published in: Breast Cancer Research and Treatment | Issue 1/2009

Login to get access

Abstract

As women age, the lobules in their breasts undergo involution. We have shown that, in women with benign breast disease, progressive involution assessed near the benign lesion is associated with lower breast cancer risk. However, it is unknown whether the extent of involution is variable or uniform across the entire breast. We compared involution across the four quadrants of both breasts for fifteen women undergoing bilateral prophylactic mastectomy. One pathologist classified involution extent as none (0% involuted lobules), mild (1–24%), moderate (25–74%), or complete (≥75%). We assessed intra-woman concordance using intraclass correlation coefficients (ICCs), kappa coefficients, and pairwise comparisons of agreement. We found strong intra-woman concordance of involution across the eight quadrants of breast tissue (ICC = 0.75, 95% CI 0.59, 0.89). Our study suggests that lobular involution is a homogeneous process, supporting the use of involution measures from a single benign biopsy as a component in breast cancer risk assessment paradigms.
Literature
1.
go back to reference Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231–273PubMed Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231–273PubMed
2.
go back to reference Vorrherr H (1974) The breast: morphology, physiology, and lactation. Academic Press, New York Vorrherr H (1974) The breast: morphology, physiology, and lactation. Academic Press, New York
4.
go back to reference Cowan DF, Herbert TA (1989) Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2(4):323–333 Cowan DF, Herbert TA (1989) Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2(4):323–333
5.
go back to reference Geschickter CF (1945) Diseases of the breast, 2nd edn. J.B. Lippincott Co., Philadelphia Geschickter CF (1945) Diseases of the breast, 2nd edn. J.B. Lippincott Co., Philadelphia
7.
go back to reference Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD et al (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600–1607PubMedCrossRef Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD et al (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600–1607PubMedCrossRef
8.
go back to reference Henson DE, Tarone RE, Nsouli H (2006) Lobular involution: the physiological prevention of breast cancer. J Natl Cancer Inst 98:1589–1590PubMed Henson DE, Tarone RE, Nsouli H (2006) Lobular involution: the physiological prevention of breast cancer. J Natl Cancer Inst 98:1589–1590PubMed
11.
go back to reference Fleiss JL (2003) Statistical methods for rates and proportions, 3rd edn. Wiley, New York Fleiss JL (2003) Statistical methods for rates and proportions, 3rd edn. Wiley, New York
13.
go back to reference McKian KP, Reynolds CA, Vierkant RA, Anderson S, Frost MH, Visscher DW et al (2008) Lobular involution: a quantitative trait directly linked to breast cancer. Lab Invest 88(Suppl 1):46A McKian KP, Reynolds CA, Vierkant RA, Anderson S, Frost MH, Visscher DW et al (2008) Lobular involution: a quantitative trait directly linked to breast cancer. Lab Invest 88(Suppl 1):46A
Metadata
Title
Lobular involution: localized phenomenon or field effect?
Authors
Robert A. Vierkant
Lynn C. Hartmann
V. Shane Pankratz
Stephanie S. Anderson
Derek Radisky
Marlene H. Frost
Celine M. Vachon
Karthik Ghosh
Tammy J. Distad
Amy C. Degnim
Carol A. Reynolds
Publication date
01-09-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0082-6

Other articles of this Issue 1/2009

Breast Cancer Research and Treatment 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine